Nikola Valuation
Is NKLA * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NKLA * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate NKLA *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate NKLA *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NKLA *?
Other financial metrics that can be useful for relative valuation.
What is NKLA *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$406.51m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 10.4x |
Enterprise Value/EBITDA | -0.6x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NKLA *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.2x | ||
TMSN Tümosan Motor ve Traktör Sanayi | 2x | n/a | ₺14.9b |
ARISTOS A Consorcio Aristos. de | 3.4x | n/a | Mex$6.9b |
ELEMAT * Elementia Materiales S. A. B. de C. V | 0.6x | n/a | Mex$11.5b |
JANTS Jantsa Jant Sanayi ve Ticaret | 2.7x | n/a | ₺19.7b |
NKLA * Nikola | 12.4x | 79.8% | Mex$406.5m |
Price-To-Sales vs Peers: NKLA * is expensive based on its Price-To-Sales Ratio (12.4x) compared to the peer average (2.4x).
Price to Earnings Ratio vs Industry
How does NKLA *'s PE Ratio compare vs other companies in the Global Machinery Industry?
Price-To-Sales vs Industry: NKLA * is expensive based on its Price-To-Sales Ratio (12.4x) compared to the Global Machinery industry average (1.5x).
Price to Sales Ratio vs Fair Ratio
What is NKLA *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 12.4x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate NKLA *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$160.55 | Mex$621.07 +286.8% | 77.4% | Mex$1,644.01 | Mex$182.67 | n/a | 6 |
Jun ’25 | Mex$259.20 | Mex$705.62 +172.2% | 59.1% | Mex$1,494.25 | Mex$249.04 | n/a | 6 |
May ’25 | Mex$324.90 | Mex$984.29 +203.0% | 43.7% | Mex$1,540.62 | Mex$513.54 | n/a | 6 |
Apr ’25 | Mex$516.00 | Mex$984.29 +90.8% | 43.7% | Mex$1,540.62 | Mex$513.54 | n/a | 6 |
Mar ’25 | Mex$374.70 | Mex$984.29 +162.7% | 43.7% | Mex$1,540.62 | Mex$513.54 | n/a | 6 |
Feb ’25 | Mex$379.50 | Mex$1,034.17 +172.5% | 40.8% | Mex$1,551.25 | Mex$517.08 | n/a | 6 |
Jan ’25 | Mex$449.70 | Mex$1,152.63 +156.3% | 53.0% | Mex$2,095.68 | Mex$523.92 | n/a | 5 |
Dec ’24 | Mex$522.60 | Mex$1,152.63 +120.6% | 53.0% | Mex$2,095.68 | Mex$523.92 | n/a | 5 |
Nov ’24 | Mex$551.70 | Mex$1,319.10 +139.1% | 62.4% | Mex$2,748.12 | Mex$549.62 | n/a | 5 |
Oct ’24 | Mex$823.20 | Mex$1,380.27 +67.7% | 49.1% | Mex$2,556.05 | Mex$511.21 | n/a | 5 |
Sep ’24 | Mex$616.50 | Mex$1,380.27 +123.9% | 49.1% | Mex$2,556.05 | Mex$511.21 | n/a | 5 |
Aug ’24 | Mex$1,590.00 | Mex$1,406.53 -11.5% | 47.4% | Mex$2,511.66 | Mex$502.33 | n/a | 5 |
Jul ’24 | Mex$715.80 | Mex$1,368.96 +91.2% | 93.5% | Mex$4,106.88 | Mex$513.36 | Mex$136.02 | 6 |
Jun ’24 | Mex$315.30 | Mex$1,440.34 +356.8% | 85.2% | Mex$4,245.22 | Mex$530.65 | Mex$259.20 | 7 |
May ’24 | Mex$482.70 | Mex$1,725.80 +257.5% | 38.3% | Mex$2,724.95 | Mex$544.99 | Mex$324.90 | 6 |
Apr ’24 | Mex$664.20 | Mex$1,802.24 +171.3% | 28.3% | Mex$2,703.36 | Mex$1,081.35 | Mex$516.00 | 6 |
Mar ’24 | Mex$1,177.20 | Mex$2,021.37 +71.7% | 30.2% | Mex$2,756.42 | Mex$1,102.57 | Mex$374.70 | 6 |
Feb ’24 | Mex$1,534.50 | Mex$3,012.72 +96.3% | 44.2% | Mex$5,648.86 | Mex$1,694.66 | Mex$379.50 | 6 |
Jan ’24 | Mex$1,260.00 | Mex$3,090.50 +145.3% | 48.0% | Mex$5,926.99 | Mex$1,481.75 | Mex$449.70 | 7 |
Dec ’23 | Mex$1,489.50 | Mex$3,318.18 +122.8% | 46.7% | Mex$5,834.17 | Mex$1,458.54 | Mex$522.60 | 8 |
Nov ’23 | Mex$2,024.70 | Mex$5,433.29 +168.4% | 23.8% | Mex$7,494.20 | Mex$3,597.21 | Mex$551.70 | 8 |
Oct ’23 | Mex$2,128.20 | Mex$5,653.73 +165.7% | 21.4% | Mex$7,488.38 | Mex$3,594.42 | Mex$823.20 | 8 |
Sep ’23 | Mex$3,223.20 | Mex$5,552.92 +72.3% | 20.9% | Mex$7,651.66 | Mex$3,672.80 | Mex$616.50 | 7 |
Aug ’23 | Mex$4,082.40 | Mex$5,763.74 +41.2% | 27.2% | Mex$9,239.59 | Mex$4,311.81 | Mex$1,590.00 | 7 |
Jul ’23 | Mex$2,863.80 | Mex$6,325.32 +120.9% | 21.2% | Mex$9,224.42 | Mex$4,919.69 | Mex$715.80 | 7 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.